Eleftherios Zarkadoulas

5PUBLICATIONS
17CO-AUTHORS
Epidemiological modellingPreventative health careMajor global burdens of disease
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jul 13, 2026
Unlocking herpes zoster vaccination value in Finland: return on investment and actuarial model.

|Mar 02, 2026
Cost Effectiveness of the Adjuvanted Recombinant Zoster Vaccine in Older Adults in Portugal.

Eleftherios Zarkadoulas, Fábio Silva, Joana Alves

|Jan 05, 2026
Reply to letter to editor "Public health impact and cost-effectiveness of the adjuvanted RSVPreF3 vaccine for respiratory syncytial virus prevention among adults aged 50 years and older in Germany".

Maria Waize, Pavo Marijic, Alen Marijam

|Jul 28, 2025
Public health impact and cost-effectiveness of the adjuvanted RSVPreF3 vaccine for respiratory syncytial virus prevention among adults aged 50 years and older in Germany.

Maria Waize, Pavo Marijic, Alen Marijam

|Jan 29, 2025
The Economic Burden of Herpes Zoster in Individuals Aged 50 Years or Older and Those With Underlying Conditions in Italy.

Eleftherios Zarkadoulas, Simona Comparoni, Riccardo Freguja

Pageof 1

Frequent Collaborators

2 joint publications

Maria Waize

2 joint publications

Pavo Marijic

2 joint publications

Alen Marijam

2 joint publications

Foteini Gkalapi